iCell Bioscience Inc. is a biotechnology company based in Shanghai, China, specializing in the development and provision of primary cells, cell lines, induced pluripotent stem cells (iPSCs), and related cell culture reagents and services. Established in 2014, iCell aims to become a global leader in cell culture, offering high-quality products and comprehensive services to support scientific research and therapeutic development .
Core Products and Services
1. Primary Cells and Cell Lines
- Over 800 types of primary human and animal cells, including tissues from liver, lung, brain, and adipose.
- More than 400 established cell lines, such as HCT116, HUVEC, BEAS-2B, and MCF-10A, widely used in cancer, cardiovascular, and immunology research .
2. iPS Cell Engineering
- Generation of iPSCs from various somatic cell types.
- iPSC differentiation services for applications in disease modeling, drug screening, and regenerative medicine.
3. Cell Culture Media and Reagents
- Specialized media formulations for primary cells, cell lines, and iPSCs.
- Supplements, growth factors, antibodies, ELISA/CLIA kits, and other reagents to support cell culture and molecular biology applications.
4. Custom Services
- Cell immortalization and engineering.
- Antibody and protein engineering.
- Viral packaging and transfection services.
- Contract research organization (CRO) and contract manufacturing organization (CMO) services.
